Pacific Biosciences Of California (PACB) Intangibles (2021 - 2026)

Pacific Biosciences Of California has reported Intangibles for 6 years, with the latest figure at $14.1 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles fell 22.43% year-over-year to $14.1 million; the trailing twelve-month figure through Mar 2026 stood at $14.1 million (down 22.43% YoY), and the FY2025 full-year result was $15.1 million, down 96.12% from the prior year.
• Intangibles for Q1 2026 stood at $14.1 million, down from $15.1 million in the prior quarter.
• The five-year high for Intangibles was $461.8 million in Q3 2023, with the low at $14.1 million in Q1 2026.
• Average Intangibles over 5 years is $304.7 million, with a median of $410.2 million recorded in 2022.
• Year-over-year, Intangibles rose 12.56% in 2023 and slumped 96.3% in 2025.
• Tracing PACB's Intangibles over 5 years: stood at $410.2 million in 2022, then gained by 11.39% to $457.0 million in 2023, then dropped by 14.75% to $389.6 million in 2024, then plunged by 96.12% to $15.1 million in 2025, then dropped by 6.74% to $14.1 million in 2026.
• The last three Intangibles figures came in at $14.1 million (Q1 2026), $15.1 million (Q4 2025), and $16.1 million (Q3 2025), per Business Quant data.

Peer Comparison